Cargando…

The relationship between HER2 overexpression and angiogenesis in gastric cancer

In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Ciesielski, Maciej, Szajewski, Mariusz, Pęksa, Rafał, Lewandowska, Marzena Anna, Zieliński, Jacek, Walczak, Jakub, Szefel, Jarosław, Kruszewski, Wiesław Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211927/
https://www.ncbi.nlm.nih.gov/pubmed/30334990
http://dx.doi.org/10.1097/MD.0000000000012854
_version_ 1783367435622023168
author Ciesielski, Maciej
Szajewski, Mariusz
Pęksa, Rafał
Lewandowska, Marzena Anna
Zieliński, Jacek
Walczak, Jakub
Szefel, Jarosław
Kruszewski, Wiesław Janusz
author_facet Ciesielski, Maciej
Szajewski, Mariusz
Pęksa, Rafał
Lewandowska, Marzena Anna
Zieliński, Jacek
Walczak, Jakub
Szefel, Jarosław
Kruszewski, Wiesław Janusz
author_sort Ciesielski, Maciej
collection PubMed
description In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER2 overexpression is related to higher microvessel density (MVD) in the tumor stroma. The archival samples of primary tumor from 144 consecutive patients that underwent gastric resection for cancer between August 1, 2006 and December 31, 2013 in the Department of Oncological Surgery of Medical University of Gdańsk were analyzed. CD34 was used as a marker of MVD in the tumor stroma. Both CD34 and HER2 protein expressions were tested by immunohistochemistry. The assays were unsuccessful to estimate HER2 in 10 cases and CD34 in 14 cases due to technical reasons. The results were obtained for 128 patients. HER2 0 and HER2 1+ were considered negative, while HER2+ and HER2 3+ were recognized as positive. Mean MVD (mean number of vessels in the visual field) was 32.4 (median 29.5). Microvessel density was insignificantly higher in HER2 positive tumors. The slight difference was also seen between IHC 2+ and 3+ groups. The differences did not reach the level of statistical significance. Statistical analysis performed in our study did not reveal the significant relationship between HER2 overexpression on the tumor cells and MVD in the tumor stroma.
format Online
Article
Text
id pubmed-6211927
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-62119272018-11-27 The relationship between HER2 overexpression and angiogenesis in gastric cancer Ciesielski, Maciej Szajewski, Mariusz Pęksa, Rafał Lewandowska, Marzena Anna Zieliński, Jacek Walczak, Jakub Szefel, Jarosław Kruszewski, Wiesław Janusz Medicine (Baltimore) Research Article In gastric cancer, HER2 protein overexpression is considered to be conducive to the higher proliferation activity of the tumor cells. Tumor formation is associated with angiogenesis in order to secure an abundant supply of oxygen and glucose to cancer cells. The aim of the study was to assess if HER2 overexpression is related to higher microvessel density (MVD) in the tumor stroma. The archival samples of primary tumor from 144 consecutive patients that underwent gastric resection for cancer between August 1, 2006 and December 31, 2013 in the Department of Oncological Surgery of Medical University of Gdańsk were analyzed. CD34 was used as a marker of MVD in the tumor stroma. Both CD34 and HER2 protein expressions were tested by immunohistochemistry. The assays were unsuccessful to estimate HER2 in 10 cases and CD34 in 14 cases due to technical reasons. The results were obtained for 128 patients. HER2 0 and HER2 1+ were considered negative, while HER2+ and HER2 3+ were recognized as positive. Mean MVD (mean number of vessels in the visual field) was 32.4 (median 29.5). Microvessel density was insignificantly higher in HER2 positive tumors. The slight difference was also seen between IHC 2+ and 3+ groups. The differences did not reach the level of statistical significance. Statistical analysis performed in our study did not reveal the significant relationship between HER2 overexpression on the tumor cells and MVD in the tumor stroma. Wolters Kluwer Health 2018-10-19 /pmc/articles/PMC6211927/ /pubmed/30334990 http://dx.doi.org/10.1097/MD.0000000000012854 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Research Article
Ciesielski, Maciej
Szajewski, Mariusz
Pęksa, Rafał
Lewandowska, Marzena Anna
Zieliński, Jacek
Walczak, Jakub
Szefel, Jarosław
Kruszewski, Wiesław Janusz
The relationship between HER2 overexpression and angiogenesis in gastric cancer
title The relationship between HER2 overexpression and angiogenesis in gastric cancer
title_full The relationship between HER2 overexpression and angiogenesis in gastric cancer
title_fullStr The relationship between HER2 overexpression and angiogenesis in gastric cancer
title_full_unstemmed The relationship between HER2 overexpression and angiogenesis in gastric cancer
title_short The relationship between HER2 overexpression and angiogenesis in gastric cancer
title_sort relationship between her2 overexpression and angiogenesis in gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6211927/
https://www.ncbi.nlm.nih.gov/pubmed/30334990
http://dx.doi.org/10.1097/MD.0000000000012854
work_keys_str_mv AT ciesielskimaciej therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT szajewskimariusz therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT peksarafał therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT lewandowskamarzenaanna therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT zielinskijacek therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT walczakjakub therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT szefeljarosław therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT kruszewskiwiesławjanusz therelationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT ciesielskimaciej relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT szajewskimariusz relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT peksarafał relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT lewandowskamarzenaanna relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT zielinskijacek relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT walczakjakub relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT szefeljarosław relationshipbetweenher2overexpressionandangiogenesisingastriccancer
AT kruszewskiwiesławjanusz relationshipbetweenher2overexpressionandangiogenesisingastriccancer